# BT1718 in Patients with Advanced Solid Tumours.

> **NCT03486730** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cancer Research UK** · enrollment: 72 (actual)

## Conditions studied

- Advanced Solid Tumours
- Non-Small Cell Lung Cancer
- Non-Small Cell Lung Sarcoma
- Oesophageal Cancer

## Interventions

- **DRUG:** BT1718

## Key facts

- **NCT ID:** NCT03486730
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03486730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03486730, "BT1718 in Patients with Advanced Solid Tumours.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03486730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*